Journal

Journal of cancer research and therapeutics
ISSN: 1998-4138
Titre abrégé: J Cancer Res Ther
Pays: India
ID NLM: 101249598

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 4 9 2020
medline: 7 9 2021
entrez: 4 9 2020
Statut: ppublish

Résumé

Leucine-rich repeat and fibronectin type 2 gene (LRFN2) variant rs2494938 has recently been found associated with esophageal cancer in a genome-wide association study in an Asian population. However, this association has not been replicated in any Indian population despite high incidence of the disease. In the present case-control study, 166 cases and 459 controls were included. Taqman assay technique using real-time PCR was employed to investigate the association of the variant with esophageal cancer in the population of Jammu and Kashmir (J&K). The Hardy-Weinberg equilibrium for rs2494938 was assessed using the Chi-square test. The allele- and genotype-specific risk was estimated by odds ratio (OR) with 95% confidence interval (CI). Variant rs2494938 was observed to be significantly associated with esophageal cancer with an allelic OR of 1.59 (1.23-2.04 at 95% CI, P = 0.0003). The study highlights LRFN2 as a candidate gene for esophageal cancer susceptibility in the population of J&K and calls for a detailed study with a large sample size and involving more ethnic groups of India.

Sections du résumé

BACKGROUND BACKGROUND
Leucine-rich repeat and fibronectin type 2 gene (LRFN2) variant rs2494938 has recently been found associated with esophageal cancer in a genome-wide association study in an Asian population. However, this association has not been replicated in any Indian population despite high incidence of the disease.
MATERIALS AND METHODS METHODS
In the present case-control study, 166 cases and 459 controls were included. Taqman assay technique using real-time PCR was employed to investigate the association of the variant with esophageal cancer in the population of Jammu and Kashmir (J&K). The Hardy-Weinberg equilibrium for rs2494938 was assessed using the Chi-square test. The allele- and genotype-specific risk was estimated by odds ratio (OR) with 95% confidence interval (CI).
RESULTS RESULTS
Variant rs2494938 was observed to be significantly associated with esophageal cancer with an allelic OR of 1.59 (1.23-2.04 at 95% CI, P = 0.0003).
CONCLUSION CONCLUSIONS
The study highlights LRFN2 as a candidate gene for esophageal cancer susceptibility in the population of J&K and calls for a detailed study with a large sample size and involving more ethnic groups of India.

Identifiants

pubmed: 32880595
pii: 283076
doi: 10.4103/jcrt.JCRT_613_19
doi:

Substances chimiques

Biomarkers, Tumor 0
LRFN2 protein, human 0
Membrane Glycoproteins 0
Nerve Tissue Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

S156-S159

Déclaration de conflit d'intérêts

None

Auteurs

Ruchi Shah (R)

Human Genetics Research Group, School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India.

Varun Sharma (V)

Human Genetics Research Group, School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India.

Hemender Singh (H)

Human Genetics Research Group, School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India.

Indu Sharma (I)

Human Genetics Research Group, School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India.

Gulzar Ahmed Bhat (GA)

Department of Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Idrees Ayoub Shah (IA)

Department of Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Beenish Iqbal (B)

Department of Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Rumisa Rafiq (R)

Department of Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Najma Nissa (N)

Department of Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Mansha Muzaffar (M)

Department of Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Malik Tariq Rasool (MT)

Department of Radiation Oncology, SK Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.

Ghulam Nabi Lone (GN)

Department of CVTS, SK Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.

Sandeep Kaul (S)

Department of Surgical Oncology, SMVDNH Superspeciality Hospital, Katra, Jammu and Kashmir, India.

Mohd Maqbool Lone (MM)

Department of Radiation Oncology, SK Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.

Ekta Rai (E)

Human Genetics Research Group, School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India.

Nazir Ahmed Dar (NA)

Department of Biochemistry, University of Kashmir, Srinagar, Jammu and Kashmir, India.

Swarkar Sharma (S)

Human Genetics Research Group, School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH